Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C D Bloomfield

Showing results (271-280 of 289) with videos related to

Pageof 29
Sort By:
Blood|May 26, 1999
Prospective karyotype analysis in adult acute lymphoblastic leukemia: the cancer and leukemia Group B experienceM Wetzler, R K Dodge, K Mrózek, et al.
Cancer|December 12, 1997
Long-term survival of patients with acute myeloid leukemia: a third follow-up of the Fourth International Workshop on Chromosomes in LeukemiaC D Bloomfield, C Shuma, L Regal, et al.
Blood|May 23, 2001
High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361)M R Baer, C C Stewart, R K Dodge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2001
Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: a Cancer and Leukemia Group B StudyK Mrózek, T W Prior, C Edwards, et al.
Annals of Hematology|May 6, 2004
Core binding factor acute myeloid leukemia. Cancer and Leukemia Group B (CALGB) Study 8461C D Bloomfield, A S Ruppert, K Mrózek, et al.
Leukemia|September 15, 2016
Maintenance therapy with decitabine in younger adults with acute myeloid leukemia in first remission: a phase 2 Cancer and Leukemia Group B Study (CALGB 10503)W Blum, B L Sanford, R Klisovic, et al.
Leukemia|March 22, 2017
The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemiaA-K Eisfeld, K Mrózek, J Kohlschmidt, et al.
Cancer Research|March 15, 1996
Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11M A Caligiuri, M P Strout, S A Schichman, et al.
Leukemia|April 22, 2006
A retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative for rare 'poor prognosis' myeloid malignanciesM L Slovak, H Gundacker, C D Bloomfield, et al.
Leukemia|June 10, 2015
Targeting leukemia stem cells in vivo with antagomiR-126 nanoparticles in acute myeloid leukemiaA M Dorrance, P Neviani, G J Ferenchak, et al.
Pageof 29

Showing results (271-280 of 289) with videos related to

Sort By:
Pageof 29
Blood|May 26, 1999
Prospective karyotype analysis in adult acute lymphoblastic leukemia: the cancer and leukemia Group B experienceM Wetzler, R K Dodge, K Mrózek, et al.
Cancer|December 12, 1997
Long-term survival of patients with acute myeloid leukemia: a third follow-up of the Fourth International Workshop on Chromosomes in LeukemiaC D Bloomfield, C Shuma, L Regal, et al.
Blood|May 23, 2001
High frequency of immunophenotype changes in acute myeloid leukemia at relapse: implications for residual disease detection (Cancer and Leukemia Group B Study 8361)M R Baer, C C Stewart, R K Dodge, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 2, 2001
Comparison of cytogenetic and molecular genetic detection of t(8;21) and inv(16) in a prospective series of adults with de novo acute myeloid leukemia: a Cancer and Leukemia Group B StudyK Mrózek, T W Prior, C Edwards, et al.
Annals of Hematology|May 6, 2004
Core binding factor acute myeloid leukemia. Cancer and Leukemia Group B (CALGB) Study 8461C D Bloomfield, A S Ruppert, K Mrózek, et al.
Leukemia|September 15, 2016
Maintenance therapy with decitabine in younger adults with acute myeloid leukemia in first remission: a phase 2 Cancer and Leukemia Group B Study (CALGB 10503)W Blum, B L Sanford, R Klisovic, et al.
Leukemia|March 22, 2017
The mutational oncoprint of recurrent cytogenetic abnormalities in adult patients with de novo acute myeloid leukemiaA-K Eisfeld, K Mrózek, J Kohlschmidt, et al.
Cancer Research|March 15, 1996
Partial tandem duplication of ALL1 as a recurrent molecular defect in acute myeloid leukemia with trisomy 11M A Caligiuri, M P Strout, S A Schichman, et al.
Leukemia|April 22, 2006
A retrospective study of 69 patients with t(6;9)(p23;q34) AML emphasizes the need for a prospective, multicenter initiative for rare 'poor prognosis' myeloid malignanciesM L Slovak, H Gundacker, C D Bloomfield, et al.
Leukemia|June 10, 2015
Targeting leukemia stem cells in vivo with antagomiR-126 nanoparticles in acute myeloid leukemiaA M Dorrance, P Neviani, G J Ferenchak, et al.
Pageof 29